Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_108b25fa685b8bfe839560275d7d9436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8540faba065c7352ee9a9fac5b7fa86 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-35 |
filingDate |
2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3e10b0d3bd7be9c3a865e18f7f50ebd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ab4e5d9084ef57f6ef3d7005130d206 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72416868ce1d5813f7296138416893a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2cb3f1a358bd4b36245ab31e36dd345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43f1099fd9870d711112e922b9450be0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e730bc540559cbba41d44cffd1e0e862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9f26d5eef876cd16a2d8036a9dd2940 |
publicationDate |
2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-102020013235-A2 |
titleOfInvention |
SYNTHETIC PEPTIDES MIMETOTOPES OF M. TUBERCULOSIS ANTIGEN PROTEIN, RECOMBINANT ANTIBODY OR FRAGMENT OF IT, APTAMERS, USE OF THESE IN THE DIAGNOSIS OF TUBERCULOSIS AND METHOD OF DIAGNOSIS OF TUBERCULOSIS |
abstract |
The present invention relates to the selection, characterization and synthesis of recombinant peptides that mimic Mycobacterium tuberculosis IgA-binding antigenic proteins from individuals with tuberculosis, as well as the selection, characterization and synthesis of aptamers and recombinant antibody fragment binding to proteins of tuberculosis. M. tuberculosis. The present invention also describes the use of both the peptides and the aptamers and the recombinant antibody fragment in diagnostic methods or platforms for diagnosing tuberculosis through biological samples from an individual, such as body fluids from tuberculosis patients. |
priorityDate |
2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |